26 results
8-K
EX-10.1
TMDX
Transmedics Group Inc
26 May 23
Departure of Directors or Certain Officers
4:31pm
), manufacturing or process development, legal compliance or risk reduction, or patent application or issuance goals. A Performance Criterion may also
8-K
EX-99.1
TMDX
Transmedics Group Inc
1 May 23
TransMedics Reports First Quarter 2023 Financial Results
4:17pm
to achieve our goals.”
First Quarter 2023 Financial Results
Total revenue for the first quarter of 2023 was $41.6 million, a 162% increase compared
8-K
EX-99.1
970iqrv 2nfm5y
9 Nov 21
TransMedics Reports Third Quarter 2021 Financial Results
4:16pm
8-K
EX-10.1
ndmsma
9 Aug 21
Departure of Directors or Certain Officers
7:26am
DEF 14A
tbzrwbjaemtd49
14 Apr 20
Definitive proxy
4:22pm
10-K
x0mna y0fsestt6v
17 Mar 20
Annual report
4:15pm
424B4
dalgst1 04g4jaj
2 May 19
Prospectus supplement with pricing info
12:00am
S-1/A
EX-10.13
1kmfam5fcbokbkynd071
22 Apr 19
IPO registration (amended)
6:11am
S-1/A
EX-10.9
ko1cfo4k6 orkidrrs
22 Apr 19
IPO registration (amended)
6:11am
S-1/A
gyhv7oeyyidll
22 Apr 19
IPO registration (amended)
6:11am
S-1
EX-10.32
ritlc qq3my4gn
5 Apr 19
IPO registration
4:13pm